Actively Recruiting
AIMS Cancer Outcomes Study
Led by Advanced Integrative Medical Science Institute · Updated on 2023-02-01
500
Participants Needed
1
Research Sites
554 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The overall aim is to describe disease-free survival (DFS) in early stage cancer patients and three-year overall survival (OS) outcomes in advanced stage cancer patients receiving Advanced Integrative Oncology (AIO) treatment in a prospective consecutive case series outcomes study. We will collect data and study outcomes for patients with cancer who receive care at AIMS Institute.
CONDITIONS
Official Title
AIMS Cancer Outcomes Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- New patient coming for first office call or consultation via telemedicine with a cancer diagnosis
- Established patient diagnosed with cancer receiving treatment at the AIMS Institute
- Adults over 18 years who can understand the study and provide signed informed consent
- Children under 18 years with informed assent and parent or guardian able to provide informed consent
- Confirmed cancer diagnosis based on medical oncology records
You will not qualify if you...
- Patients not diagnosed with cancer
- Telehealth patients
- Unable to read or understand English well enough to consent and complete questionnaires
- Unwilling to participate in the AIMS Institute observational study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
AIMS Institute
Seattle, Washington, United States, 98102
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here